Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelofibrosis, Polycythaemia, Thrombocythaemia
Closed
Phase 1
This trial is for people with advanced myeloproliferative neoplasms that include thrombocythaemia, polycythaemia vera or myelofibrosis.
Recruitment start: 5 January 2016
Recruitment end: 30 April 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Drummond
Bloodwise
Celgene
Novartis
University of Birmingham
Last reviewed: 29 April 2019
CRUK internal database number: 12130